Invasive lobular carcinoma: response to neoadjuvant letrozole therapy

Abstract 175: Lack of rDNA promoter hypomethylation in clinical prostate cancer specimens and cell lines

(2011) Motohide Uemura et al.   CANCER RESEARCH

Reply to M. Ozsahin et al

(2010) George P. Canellos   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation

(2009) Judy C. Boughey et al.   ANNALS OF SURGICAL ONCOLOGY

The Yale University Experience of Early-Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical-Pathologic Features, Long-Term Outcomes, and Molecular Expression of COX-2, Bcl-2, and p53 as a Function of Histology

(2009) Meena S. Moran et al.   Breast Journal

Increase in response rate by prolonged treatment with neoadjuvant letrozole

(2008) J. Michael Dixon et al.   BREAST CANCER RESEARCH AND TREATMENT

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

(2008) J. Geisler et al.   CLINICAL CANCER RESEARCH

Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer

(2008) J. Michael Dixon et al.   JOURNAL OF CLINICAL ONCOLOGY